申请人:Roche Palo Alto LLC
公开号:US20040220247A1
公开(公告)日:2004-11-04
Compounds effective as IP receptor modulators, particularly IP receptor antagonists, that are of the formula I:
1
wherein A, R
1
, R
2
, R
3
and R
4
are as defined in the specification; and individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates thereof. Also disclosed are pharmaceutical compositions containing such compounds and methods for their use as therapeutic agents.
本发明涉及有效的IP受体调节剂,特别是IP受体拮抗剂,其化学式为I:1,其中A、R1、R2、R3和R4如规范中所定义;以及其各个异构体、外消旋或非外消旋异构体混合物及其药学上可接受的盐或溶剂。本发明还公开了包含这些化合物的制药组合物以及它们作为治疗剂的使用方法。